Hampton GM - Search Results

1

Overlapping gene expression profiles of cell migration and tumor invasion in human bladder cancer identify metallothionein 1E and nicotinamide N-methyltransferase as novel regulators of cell migration.

Wu Y, Siadaty MS, Berens ME, Hampton GM, Theodorescu D. Wu Y, et al. Among authors: hampton gm. Oncogene. 2008 Nov 6;27(52):6679-89. doi: 10.1038/onc.2008.264. Epub 2008 Aug 25. Oncogene. 2008. PMID: 18724390 Free PMC article.

2

Expression profiling of Ral-depleted bladder cancer cells identifies RREB-1 as a novel transcriptional Ral effector.

Oxford G, Smith SC, Hampton G, Theodorescu D. Oxford G, et al. Oncogene. 2007 Nov 1;26(50):7143-52. doi: 10.1038/sj.onc.1210521. Epub 2007 May 14. Oncogene. 2007. PMID: 17496927

3

A novel method for gene expression mapping of metastatic competence in human bladder cancer.

Wu Z, Siadaty MS, Riddick G, Frierson HF Jr, Lee JK, Golden W, Knuutila S, Hampton GM, El-Rifai W, Theodorescu D. Wu Z, et al. Among authors: hampton gm. Neoplasia. 2006 Mar;8(3):181-9. doi: 10.1593/neo.05727. Neoplasia. 2006. PMID: 16611411 Free PMC article.

4

Endothelin axis is a target of the lung metastasis suppressor gene RhoGDI2.

Titus B, Frierson HF Jr, Conaway M, Ching K, Guise T, Chirgwin J, Hampton G, Theodorescu D. Titus B, et al. Cancer Res. 2005 Aug 15;65(16):7320-7. doi: 10.1158/0008-5472.CAN-05-1403. Cancer Res. 2005. PMID: 16103083

5

The metastasis-associated gene CD24 is regulated by Ral GTPase and is a mediator of cell proliferation and survival in human cancer.

Smith SC, Oxford G, Wu Z, Nitz MD, Conaway M, Frierson HF, Hampton G, Theodorescu D. Smith SC, et al. Cancer Res. 2006 Feb 15;66(4):1917-22. doi: 10.1158/0008-5472.CAN-05-3855. Cancer Res. 2006. PMID: 16488989

6

Prediction of drug combination chemosensitivity in human bladder cancer.

Havaleshko DM, Cho H, Conaway M, Owens CR, Hampton G, Lee JK, Theodorescu D. Havaleshko DM, et al. Mol Cancer Ther. 2007 Feb;6(2):578-86. doi: 10.1158/1535-7163.MCT-06-0497. Mol Cancer Ther. 2007. PMID: 17308055

7

Profiling bladder cancer organ site-specific metastasis identifies LAMC2 as a novel biomarker of hematogenous dissemination.

Smith SC, Nicholson B, Nitz M, Frierson HF Jr, Smolkin M, Hampton G, El-Rifai W, Theodorescu D. Smith SC, et al. Am J Pathol. 2009 Feb;174(2):371-9. doi: 10.2353/ajpath.2009.080538. Epub 2009 Jan 15. Am J Pathol. 2009. PMID: 19147813 Free PMC article.

8

RhoGDI2 is an invasion and metastasis suppressor gene in human cancer.

Gildea JJ, Seraj MJ, Oxford G, Harding MA, Hampton GM, Moskaluk CA, Frierson HF, Conaway MR, Theodorescu D. Gildea JJ, et al. Among authors: hampton gm. Cancer Res. 2002 Nov 15;62(22):6418-23. Cancer Res. 2002. PMID: 12438227

9

Profiling the evolution of human metastatic bladder cancer.

Nicholson BE, Frierson HF, Conaway MR, Seraj JM, Harding MA, Hampton GM, Theodorescu D. Nicholson BE, et al. Among authors: hampton gm. Cancer Res. 2004 Nov 1;64(21):7813-21. doi: 10.1158/0008-5472.CAN-04-0826. Cancer Res. 2004. PMID: 15520187

10

Cdc6 and cyclin E2 are PTEN-regulated genes associated with human prostate cancer metastasis.

Wu Z, Cho H, Hampton GM, Theodorescu D. Wu Z, et al. Among authors: hampton gm. Neoplasia. 2009 Jan;11(1):66-76. doi: 10.1593/neo.81048. Neoplasia. 2009. PMID: 19107233 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters